$Bristol-Myers Squibb(BMY)$ vi

$Bristol-Myers Squibb(BMY)$ view order details.@Trade Feed Decoder

BMY

10-10 21:29

USBristol-Myers Squibb

Side	Price \| Filled	Realized P&L
Buy Open	44.48 200	-- Closed

Bristol-Myers Squibb

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
10-10
Trade Feed Decoder
This BMY trade shows a minor realized loss of -0.77% at $44.48 entry. While the limited P&L data suggests a short-term exit, Bristol-Myers' fundamental position as a dividend aristocrat with 5.3% yield and pipeline assets like Sotyktu might indicate a value-oriented thesis. The timing aligns with recent sector volatility, as healthcare stocks faced pressure from drug pricing debates in Q2 2023. However, the quick exit contrasts with BMY's typical institutional holding patterns. Traders could analyze whether this reflects tactical position-sizing in a diversified portfolio or hesitation about near-term patent cliffs. The narrow loss percentage implies disciplined risk management, though pharma investors generally prioritize longer timelines for pipeline catalysts to materialize.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":487750350086224,"tweetId":"487750350086224","gmtCreate":1760103062639,"gmtModify":1762956722172,"author":{"id":3564014836032088,"idStr":"3564014836032088","authorId":3564014836032088,"authorIdStr":"3564014836032088","name":"惆怅人间客","avatar":"https://static.tigerbbs.com/0d3944b70ec12dc91edbbf339f306077","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.04","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":0,"starInvestorOrderShareNum":15,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":140.56,"showRor":true,"winRationPercentage":70.588235,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/BMY\">$Bristol-Myers Squibb(BMY)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/BMY\">$Bristol-Myers Squibb(BMY)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Bristol-Myers Squibb(BMY)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/487750350086224","repostId":0,"isVote":1,"tweetType":1,"viewCount":114,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BMY"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3564014836032088","orderId":"40767646665411584","kind":"TRADE","symbol":"BMY","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/BMY\">$Bristol-Myers Squibb(BMY)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/BMY","symbolName":"Bristol-Myers Squibb","market":"US","action":"BUY","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"Bristol-Myers Squibb","orderType":"LMT","filledQuantityFinal":200,"avgFillPrice":44.48,"createTime":1760102999,"filledQuantity":"200","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"Bristol-Myers Squibb","contractExtraDescription":"BMY","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":0.056},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":487777712099728,"commentId":"487777712099728","gmtCreate":1760109634254,"gmtModify":1760109638903,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":487750350086224,"objectIdStr":"487750350086224","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"This BMY trade shows a minor realized loss of -0.77% at $44.48 entry. While the limited P&amp;L data suggests a short-term exit, Bristol-Myers' fundamental position as a dividend aristocrat with 5.3% yield and pipeline assets like Sotyktu might indicate a value-oriented thesis. The timing aligns with recent sector volatility, as healthcare stocks faced pressure from drug pricing debates in Q2 2023. However, the quick exit contrasts with BMY's typical institutional holding patterns. Traders could analyze whether this reflects tactical position-sizing in a diversified portfolio or hesitation about near-term patent cliffs. The narrow loss percentage implies disciplined risk management, though pharma investors generally prioritize longer timelines for pipeline catalysts to materialize.","text":"This BMY trade shows a minor realized loss of -0.77% at $44.48 entry. While the limited P&amp;L data suggests a short-term exit, Bristol-Myers' fundamental position as a dividend aristocrat with 5.3% yield and pipeline assets like Sotyktu might indicate a value-oriented thesis. The timing aligns with recent sector volatility, as healthcare stocks faced pressure from drug pricing debates in Q2 2023. However, the quick exit contrasts with BMY's typical institutional holding patterns. Traders could analyze whether this reflects tactical position-sizing in a diversified portfolio or hesitation about near-term patent cliffs. The narrow loss percentage implies disciplined risk management, though pharma investors generally prioritize longer timelines for pipeline catalysts to materialize.","html":"This BMY trade shows a minor realized loss of -0.77% at $44.48 entry. While the limited P&amp;L data suggests a short-term exit, Bristol-Myers' fundamental position as a dividend aristocrat with 5.3% yield and pipeline assets like Sotyktu might indicate a value-oriented thesis. The timing aligns with recent sector volatility, as healthcare stocks faced pressure from drug pricing debates in Q2 2023. However, the quick exit contrasts with BMY's typical institutional holding patterns. Traders could analyze whether this reflects tactical position-sizing in a diversified portfolio or hesitation about near-term patent cliffs. The narrow loss percentage implies disciplined risk management, though pharma investors generally prioritize longer timelines for pipeline catalysts to materialize.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/487750350086224"}